You searched for: plasmakoncentration (Svenska - Engelska)

plasmakoncentration
plasmatic level

plasmakoncentration.
concentrations of

plasmakoncentration av
the plasma concentrations of

tenofovirs plasmakoncentration.
tenofovir plasma concentrations.

auc och maximal plasmakoncentration
in hiv− infected paediatric patients, a dosage regimen of indinavir hard capsules, 500 mg/ m2 every 8 hours, produced auc0– 8hr values of 27,412 nm*h, peak plasma concentrations of 12,182 nm, and plasma concentrations at 8 hours post dose of 122 nm.

plasmakoncentration av simeprevir förväntas.
concentrations of simeprevir are expected.

monitorering av metadons plasmakoncentration rekommenderas.
monitoring plasma concentrations of methadone is recommended.

dolutegravirs plasmakoncentration mildrades genom samtidig
etravirine on dolutegravir plasma concentrations was mitigated by

substanser vars plasmakoncentration kan förändras av ceritinib
agents whose plasma concentration may be altered by ceritinib

hämningen är nära relaterad till tolkapons plasmakoncentration.
the inhibition is closely related to plasma tolcapone concentration.

maximal plasmakoncentration uppnås inom 1 till 2 timmar.
the peak plasma concentration is reached within 1 to 2 hours.

aktiva substanser vars plasmakoncentration kan förändras av glivec
active substances that may have their plasma concentration altered by glivec

risperidons plasmakoncentration är dosproportionell inom det terapeutiska dosintervallet.
risperidone plasma concentrations are dose-proportional within the therapeutic dose-range.

det finns ett linjärt samband mellan dos och plasmakoncentration.
there is a linear correlation between dose and plasma concentration.

plasmakoncentration vid steady state uppnås inom 5 dagars behandling.
steady state plasma concentrations are reached within 5 days of treatment.

maximal plasmakoncentration erhålls efter cirka 2 - 3 timmar.
maximal plasma concentrations are obtained after approximately 2–3 hours.

maximal plasmakoncentration observerades 0,5 till 1,0 timme efter dosering.
peak plasma concentration was observed 0.5 to 1.0 hour after dosing.

efter oral administrering uppnås maximal plasmakoncentration efter ca 5 timmar.
maximum rosuvastatin plasma concentrations are achieved approximately 5 hours after oral administration.

maximal plasmakoncentration uppnås inom ca 0,24 timmar efter intramuskulär administrering.
the maximum plasma concentration is reached about 0.24 h after intramuscular administration.

maximal plasmakoncentration uppnås i allmänhet 6- 8 timmar efter administrering.
maximum plasma concentration is generally achieved 6 to 8 hours after administration.